| H3Africa AWI-Gen Collaborative Centre: a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African … M Ramsay, N Crowther, E Tambo, G Agongo, V Baloyi, S Dikotope, ... Global health, epidemiology and genomics 1, e20, 2016 | 125 | 2016 |
| Genomic and environmental risk factors for cardiometabolic diseases in Africa: methods used for Phase 1 of the AWI-Gen population cross-sectional study SA Ali, C Soo, G Agongo, M Alberts, L Amenga-Etego, RP Boua, ... Global health action 11 (sup2), 1507133, 2018 | 86 | 2018 |
| First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies S Dellicour, E Sevene, R McGready, H Tinto, D Mosha, C Manyando, ... PLoS medicine 14 (5), e1002290, 2017 | 86 | 2017 |
| Socioeconomic and environmental factors associated with malaria hotspots in the Nanoro demographic surveillance area, Burkina Faso T Rouamba, S Nakanabo-Diallo, K Derra, E Rouamba, A Kazienga, ... BMC public health 19, 1-14, 2019 | 55 | 2019 |
| Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso P Sondo, K Derra, T Rouamba, S Nakanabo Diallo, P Taconet, ... Parasites & vectors 13, 1-12, 2020 | 45 | 2020 |
| Classical cardiovascular risk factors and HIV are associated with carotid intima‐media thickness in adults from Sub‐Saharan Africa: findings from H3Africa AWI‐Gen study EA Nonterah, PR Boua, K Klipstein‐Grobusch, G Asiki, LK Micklesfield, ... Journal of the American Heart Association 8 (14), e011506, 2019 | 29 | 2019 |
| Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique H Tinto, E Sevene, S Dellicour, GS Calip, U d’Alessandro, E Macete, ... Reproductive health 12, 1-9, 2015 | 24 | 2015 |
| First Investigative Study of Azole-Resistant Aspergillus fumigatus in the Environment in Burkina Faso IW Yerbanga, A Resendiz-Sharpe, S Bamba, K Lagrou, ... International journal of environmental research and public health 18 (5), 2250, 2021 | 11 | 2021 |
| First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age O Augusto, A Stergachis, S Dellicour, H Tinto, A Valá, M Ruperez, ... Malaria journal 19, 1-15, 2020 | 11 | 2020 |
| Optimal approach and strategies to strengthen pharmacovigilance in sub-Saharan Africa: a cohort study of patients treated with first-line artemisinin-based combination … T Rouamba, P Sondo, K Derra, S Nakanabo-Diallo, B Bihoun, ... Drug Design, Development and Therapy, 1507-1521, 2020 | 11 | 2020 |
| Gender differences in sociodemographic and behavioural factors associated with BMI in an adult population in rural Burkina Faso–an AWI-Gen sub-study RP Boua, H Sorgho, T Rouamba, S Nakanabo Diallo, JD Bognini, ... Global health action 11 (sup2), 1527557, 2018 | 11 | 2018 |
| Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage … P Sondo, B Bihoun, MC Tahita, K Derra, T Rouamba, S Nakanabo Diallo, ... Malaria journal 20, 1-11, 2021 | 7 | 2021 |
| Environmental characteristics and evolution of malaria hotspots in a rural area, Burkina Faso T Rouamba, S Nakanabo-Diallo, K Derra, E Rouamba, S Kankoe, P Yaka, ... TROPICAL MEDICINE & INTERNATIONAL HEALTH 22, 224-224, 2017 | 1 | 2017 |
| First detection of triazole‐resistant aspergillus fumigatus harbouring the TR34/L98H Cyp51A mutation in Burkina Faso IW Yerbanga, K Lagrou, R Merckx, S Nakanabo Diallo, JP Gangneux, ... Mycoses 67 (5), e13732, 2024 | | 2024 |
| First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies H Tinto, C Manyando, M Oneko, D Mosha, EM Njunju, R McGready, ... PLOS ONE, 2016 | | 2016 |
